M M Braun

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. ncbi request reprint Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS)
    M M Braun
    Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20852, USA
    Pediatrics 106:E51. 2000
  2. ncbi request reprint Postlicensure safety surveillance for varicella vaccine
    R P Wise
    Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, FDA CBER HFM 225, Rockville, MD 20852 1448, USA
    JAMA 284:1271-9. 2000
  3. ncbi request reprint Stevens-Johnson syndrome and toxic epidermal necrolysis after vaccination: reports to the vaccine adverse event reporting system
    R Ball
    The Vaers Working Group Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD, USA
    Pediatr Infect Dis J 20:219-23. 2001
  4. ncbi request reprint Data mining in the US Vaccine Adverse Event Reporting System (VAERS): early detection of intussusception and other events after rotavirus vaccination
    M T Niu
    Vaccine Safety Branch, Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologic Evaluation and Research, US Food and Drug Administration, 1401 Rockville Pike, HFM 210, Rockville, MD 20852 1448, USA
    Vaccine 19:4627-34. 2001
  5. ncbi request reprint Safety data on meningococcal polysaccharide vaccine from the Vaccine Adverse Event Reporting System
    R Ball
    Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, US Food and Drug Administration, Rockville, MD 20852, USA
    Clin Infect Dis 32:1273-80. 2001

Detail Information

Publications5

  1. ncbi request reprint Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS)
    M M Braun
    Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20852, USA
    Pediatrics 106:E51. 2000
    ..To evaluate the safety of infant immunization with acellular pertussis vaccines in the United States...
  2. ncbi request reprint Postlicensure safety surveillance for varicella vaccine
    R P Wise
    Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, FDA CBER HFM 225, Rockville, MD 20852 1448, USA
    JAMA 284:1271-9. 2000
    ....
  3. ncbi request reprint Stevens-Johnson syndrome and toxic epidermal necrolysis after vaccination: reports to the vaccine adverse event reporting system
    R Ball
    The Vaers Working Group Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD, USA
    Pediatr Infect Dis J 20:219-23. 2001
    ..We identified six cases of SJS or TEN after vaccination without other obvious triggers, suggesting that SJS and TEN might very rarely be caused by vaccination. Confirmation of this hypothesis will likely require controlled studies...
  4. ncbi request reprint Data mining in the US Vaccine Adverse Event Reporting System (VAERS): early detection of intussusception and other events after rotavirus vaccination
    M T Niu
    Vaccine Safety Branch, Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologic Evaluation and Research, US Food and Drug Administration, 1401 Rockville Pike, HFM 210, Rockville, MD 20852 1448, USA
    Vaccine 19:4627-34. 2001
    ..Data mining appears to be an efficient and effective computer-based program that may enhance early detection of adverse events in passive surveillance systems...
  5. ncbi request reprint Safety data on meningococcal polysaccharide vaccine from the Vaccine Adverse Event Reporting System
    R Ball
    Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, US Food and Drug Administration, Rockville, MD 20852, USA
    Clin Infect Dis 32:1273-80. 2001
    ..That there were few reports of serious adverse events, with >6 million doses having been distributed, and no clear signal of a previously unrecognized serious reaction is reassuring with regard to the safety of meningococcal vaccine...